MeiraGTx Holdings PLC MGTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
6.09quote price arrow up+0.02 (+0.33%)
Volume
4,481
Close
6.07UNCH (UNCH)
Volume
170,846
52 week range
3.49 - 8.35
Loading...
  • Open6.20
  • Day High6.22
  • Day Low5.97
  • Prev Close6.21
  • 52 Week High8.35
  • 52 Week High Date06/09/23
  • 52 Week Low3.49
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap386.058M
  • Shares Out63.60M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-13.53

KEY STATS

  • Open6.20
  • Day High6.22
  • Day Low5.97
  • Prev Close6.21
  • 52 Week High8.35
  • 52 Week High Date06/09/23
  • 52 Week Low3.49
  • 52 Week Low Date10/25/23
  • Market Cap386.058M
  • Shares Out63.60M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-13.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.58
  • P/E (TTM)-3.85
  • Fwd P/E (NTM)-3.71
  • EBITDA (TTM)-123.331M
  • ROE (TTM)-65.67%
  • Revenue (TTM)14.017M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-599.47%
  • Debt To Equity (MRQ)52.19%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MeiraGTx Holdings PLC

 

Profile

MORE
MeiraGTx Holdings PLC is an integrated, clinical stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. It has six programs in clinical development and a pipeline of preclinical and research programs. The Company’s product pipeline includes Botaretigene Sparoparvovec...
Keith Harris Ph.D.
Independent Chairman of the Board
Alexandria Forbes Ph.D.
President, Chief Executive Officer, Director
Richard Giroux
Chief Financial Officer, Chief Operating Officer
Robert Wollin J.D.
General Counsel, Secretary
Address
450 E 29th St Fl 15
New York, NY
10016-8367
United States

Top Peers

SYMBOLLASTCHG%CHG
ITOS
Iteos Therapeutics Inc
13.64UNCHUNCH
TCRX
TScan Therapeutics Inc
7.94UNCHUNCH
AURA
Aura Biosciences Inc
7.85UNCHUNCH
OCGN
Ocugen Inc
1.64UNCHUNCH
GLUE
Monte Rosa Therapeutics Inc
7.05UNCHUNCH